Centessa Pharmaceuticals (CNTA)
39.67
-0.02 (0.05%)
Upcoming Events
Latest Headlines
Actinium Pharmaceuticals names Steffen Heeger as chief medical officer
June 1, 2026 8:01 AM - StreetInsider
Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
June 1, 2026 8:00 AM - PR NewsWire
Form 8-K Centessa Pharmaceuticals For: May 21
May 22, 2026 4:17 PM - SEC Filing
Form 4 Centessa Pharmaceuticals For: May 01 Filed by: Accardi Mario Alberto
May 18, 2026 9:45 PM - SEC Filing
Form SCHEDULE 13G Centessa Pharmaceuticals Filed by: Pentwater Capital Management LP
May 15, 2026 4:40 PM - SEC Filing
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Avoro Capital Advisors LLC
May 15, 2026 8:19 AM - SEC Filing
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Adage Capital Management, L.P.
May 13, 2026 9:02 AM - SEC Filing
Form DEFM14A Centessa Pharmaceuticals
May 7, 2026 7:01 AM - SEC Filing
Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
May 6, 2026 11:07 AM - SEC Filing
Form 10-Q Centessa Pharmaceuticals For: Mar 31
May 5, 2026 4:05 PM - SEC Filing
Form ARS Centessa Pharmaceuticals For: Dec 31
April 29, 2026 8:03 AM - SEC Filing
Form DEF 14A Centessa Pharmaceuticals For: Jun 12
April 29, 2026 8:00 AM - SEC Filing
Wells Fargo Downgrades Centessa Pharmaceuticals (CNTA) to Equal Weight
April 20, 2026 5:14 AM - StreetInsider
Form PREM14A Centessa Pharmaceuticals For: Apr 17
April 17, 2026 4:45 PM - SEC Filing
Form DEFA14A Centessa Pharmaceuticals
April 13, 2026 5:27 PM - SEC Filing
Truist Securities Downgrades Centessa Pharmaceuticals (CNTA) to Hold
April 13, 2026 1:49 AM - StreetInsider
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
April 7, 2026 7:31 AM - StreetInsider
Centessa Pharmaceuticals (CNTA) 5600 contracts of January 35 puts trade
April 1, 2026 3:10 PM - StreetInsider
Guggenheim Downgrades Centessa Pharmaceuticals (CNTA) to Neutral
April 1, 2026 12:02 PM - StreetInsider
Leerink Partners Downgrades Centessa Pharmaceuticals (CNTA) to Market Perform
April 1, 2026 6:21 AM - StreetInsider
Form DEFA14A Centessa Pharmaceuticals
March 31, 2026 4:39 PM - SEC Filing
Form DEFA14A Centessa Pharmaceuticals
March 31, 2026 4:37 PM - SEC Filing
Form DEFA14A Centessa Pharmaceuticals
March 31, 2026 4:35 PM - SEC Filing
Form DEFA14A Centessa Pharmaceuticals
March 31, 2026 4:35 PM - SEC Filing
Form S-8 Centessa Pharmaceuticals
March 31, 2026 4:35 PM - SEC Filing
Form 10-K Centessa Pharmaceuticals For: Dec 31
March 31, 2026 4:33 PM - SEC Filing
Form DEFA14A Centessa Pharmaceuticals
March 31, 2026 4:24 PM - SEC Filing
Form 8-K Centessa Pharmaceuticals For: Mar 31
March 31, 2026 4:23 PM - SEC Filing
Wolfe Research Downgrades Centessa Pharmaceuticals (CNTA) to Peerperform
March 31, 2026 11:03 AM - StreetInsider
Centessa Pharmaceuticals (CNTA) call put ratio 3.7 calls to 1 put after Eli Lilly (LLY) acquiring
March 31, 2026 10:07 AM - StreetInsider
B.Riley Downgrades Centessa Pharmaceuticals (CNTA) to Neutral
March 31, 2026 9:32 AM - StreetInsider
Form DFAN14A Centessa Pharmaceuticals Filed by: ELI LILLY & Co
March 31, 2026 8:19 AM - SEC Filing
Stephens Downgrades Centessa Pharmaceuticals (CNTA) to Equal Weight
March 31, 2026 8:18 AM - StreetInsider
Needham Downgrades Centessa Pharmaceuticals (CNTA) to Hold
March 31, 2026 8:13 AM - StreetInsider
Centessa shares surge after Lilly unveils $6.3 billion takeover deal
March 31, 2026 7:23 AM - StreetInsider
Lilly to acquire Centessa for $6.3 billion to expand sleep disorder treatments
March 31, 2026 6:45 AM - StreetInsider
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
March 31, 2026 6:45 AM - PR NewsWire
Form 4 Centessa Pharmaceuticals For: Mar 26 Filed by: Anderson Karen M.
March 27, 2026 6:17 PM - SEC Filing
Form 4 Centessa Pharmaceuticals For: Mar 26 Filed by: Weinhoff Gregory M
March 26, 2026 8:36 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Weinhoff Gregory M
March 26, 2026 4:22 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Anderson Karen M.
March 26, 2026 4:06 PM - SEC Filing
Form 4 Centessa Pharmaceuticals For: Mar 16 Filed by: Anderson Karen M.
March 18, 2026 6:44 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Anderson Karen M.
March 17, 2026 4:03 PM - SEC Filing
Form 4/A Centessa Pharmaceuticals For: Mar 13 Filed by: Anderson Karen M.
March 16, 2026 6:10 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Anderson Karen M.
March 16, 2026 4:24 PM - SEC Filing
Form 4 Centessa Pharmaceuticals For: Mar 13 Filed by: Anderson Karen M.
March 13, 2026 6:23 PM - SEC Filing
Form 4 Centessa Pharmaceuticals For: Mar 13 Filed by: Weinhoff Gregory M
March 13, 2026 6:23 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Anderson Karen M.
March 13, 2026 5:05 PM - SEC Filing
Form 144 Centessa Pharmaceuticals Filed by: Weinhoff Gregory M
March 13, 2026 4:10 PM - SEC Filing
Full Article List